Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
Open accessThe DOI matches its OpenAlex record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Tubulointerstitial fibrosis is the final common result of a variety of progressive injuries leading to chronic renal failure. Transforming growth factor-beta (TGF-beta) is reportedly upregulated in response to injurious stimuli such as unilateral ureteral obstruction (UUO), causing renal fibrosis associated with epithelial-mesenchymal transition (EMT) of the renal tubules and synthesis of extracellular matrix. We now show that mice lacking Smad3 (Smad3ex8/ex8), a key signaling intermediate downstream of the TGF-beta receptors, are protected against tubulointerstitial fibrosis following UUO as evidenced by blocking of EMT and abrogation of monocyte influx and collagen accumulation. Culture of primary renal tubular epithelial cells from wild-type or Smad3-null mice confirms that the Smad3 pathway is essential for TGF-beta1-induced EMT and autoinduction of TGF-beta1. Moreover, mechanical stretch of the cultured epithelial cells, mimicking renal tubular distention due to accumulation of urine after UUO, induces EMT following Smad3-mediated upregulation of TGF-beta1. Exogenous bone marrow monocytes accelerate EMT of the cultured epithelial cells and renal tubules in the obstructed kidney after UUO dependent on Smad3 signaling. Together the data demonstrate that the Smad3 pathway is central to the pathogenesis of interstitial fibrosis and suggest that inhibitors of this pathway may have clinical application in the treatment of obstructive nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719 · cited 2×
“The Snail family of zinc-finger transcription factors are strong repressors of transcription of the E-cadherin gene and are implicated in both physiological and pathological EMT (18, 19, 33, 34).”
Evidence that fibroblasts derive from epithelium during tissue fibrosis
Iwano, M., Plieth, D., Danoff, T. M., Xue, C., Okada, H., & Neilson, E. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215518 · Cited by 1,590
An Overview of Epithelio-Mesenchymal Transformation
Hay, E. D. (1995) · Cells Tissues Organs · doi:10.1159/000147748 · Cited by 1,567
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272
Self-citationPathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Cited by
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M., & Nieto, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38019 · Cited by 1,370
TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology
Morikawa, M., Derynck, R., & Miyazono, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021873 · Cited by 1,321
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Biernacka, A., Dobaczewski, M., & Frangogiannis, N. G. (2011) · Growth Factors · doi:10.3109/08977194.2011.595714 · Cited by 1,161
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
Willis, B. C., & Borok, Z. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00163.2007 · Cited by 1,042
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Moustakas, A., & Heldin, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00550.x · Cited by 804
Grande, M. T., Sánchez-Laorden, B., López-Blau, C., De Frutos, C. A., Boutet, A., Arévalo, M., Rowe, R. G., Weiss, S. J., López-Novoa, J. M., & Nieto, M. A. (2015) · Nature Medicine · doi:10.1038/nm.3901 · Cited by 783
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 756
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression
López‐Novoa, J. M., & Nieto, M. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900043 · Cited by 654
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Smad3 as a mediator of the fibrotic response
Flanders, K. C. (2004) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2004.00377.x · Cited by 608
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Galectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
EMT as the ultimate survival mechanism of cancer cells
Tiwari, N., Gheldof, A., Tatari, M., & Christofori, G. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.013 · Cited by 512
Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503
Oxidative stress and glutathione in TGF-β-mediated fibrogenesis
Liu, R.-M., & Gaston Pravia, K. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.026 · Cited by 469
Imatinib mesylate blocks a non‐Smad TGF‐β pathway and reduces renal fibrogenesis in vivo
Wang, S., Wilkes, M. C., Leof, E. B., & Hirschberg, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-2370com · Cited by 463
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Kriz, W., Kaissling, B., & Le Hir, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44595 · Cited by 455
Wang, Y.-Y., Jiang, H., Pan, J., Huang, X.-R., Wang, Y.-C., Huang, H.-F., To, K.-F., Nikolic-Paterson, D. J., Lan, H.-Y., & Chen, J.-H. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050573 · Cited by 430
Transforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385
Hackett, T.-L., Warner, S. M., Stefanowicz, D., Shaheen, F., Pechkovsky, D. V., Murray, L. A., Argentieri, R., Kicic, A., Stick, S. M., Bai, T. R., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1730oc · Cited by 383
Cytokine mediated tissue fibrosis
Borthwick, L. A., Wynn, T. A., & Fisher, A. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.014 · Cited by 375
IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
CHUNG, L. W. K., BASEMAN, A., ASSIKIS, V., & ZHAU, H. E. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 361
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Pardali, E., Sanchez-Duffhues, G., Gomez-Puerto, M., & Ten Dijke, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102157 · Cited by 360
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
Meng, X.-M., Chung, A. C. K., & Lan, H. Y. (2013) · Clinical Science · doi:10.1042/cs20120252 · Cited by 354
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
ROBERTS, A., TIAN, F., BYFIELD, S., STUELTEN, C., OOSHIMA, A., SAIKA, S., & FLANDERS, K. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.008 · Cited by 348
Self-citationTransforming growth factor‐β and Smad signalling in kidney diseases: Review Article
WANG, W., KOKA, V., & LAN, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
Bielesz, B., Sirin, Y., Si, H., Niranjan, T., Gruenwald, A., Ahn, S., Kato, H., Pullman, J., Gessler, M., Haase, V. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43025 · Cited by 345
Intestinal fibrosis in IBD—a dynamic, multifactorial process
Rieder, F., & Fiocchi, C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.31 · Cited by 343
TGF-β in Renal Injury and Disease
Böttinger, E. P. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.009 · Cited by 339
Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338
Progression in Chronic Kidney Disease
Eddy, A. A. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.07.011 · Cited by 337
MIYAZONO, K. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.314 · Cited by 337
Regulation of endothelial cell plasticity by TGF-β
van Meeteren, L. A., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1222-6 · Cited by 333
Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney
Boutet, A., De Frutos, C. A., Maxwell, P. H., Mayol, M. J., Romero, J., & Nieto, M. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601421 · Cited by 327
Epithelial-mesenchymal Transition and Cell Invasion
Son, H.-J., & Moon, A. (2010) · Toxicological Research · doi:10.5487/tr.2010.26.4.245 · Cited by 320
Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments
Martínez-Klimova, E., Aparicio-Trejo, O. E., Tapia, E., & Pedraza-Chaverri, J. (2019) · Biomolecules · doi:10.3390/biom9040141 · Cited by 319
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317
Li, J., Qu, X., & Bertram, J. F. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090096 · Cited by 316
Fuxe, J., Vincent, T., & Garcia de Herreros, A. (2010) · Cell Cycle · doi:10.4161/cc.9.12.12050 · Cited by 311
Kim, D., Xing, T., Yang, Z., Dudek, R., Lu, Q., & Chen, Y.-H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm7010001 · Cited by 306
TGF-β 1/Smads and miR-21 in Renal Fibrosis and Inflammation
Loboda, A., Sobczak, M., Jozkowicz, A., & Dulak, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/8319283 · Cited by 297
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Xiao, J., Meng, X.-M., Huang, X. R., Chung, A. C., Feng, Y.-L., Hui, D. S., Yu, C.-M., Sung, J. J., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.36 · Cited by 293
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
Tan, X., Li, Y., & Liu, Y. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050520 · Cited by 280
Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
Wang, Q., Usinger, W., Nichols, B., Gray, J., Xu, L., Seeley, T. W., Brenner, M., Guo, G., Zhang, W., Oliver, N., et al. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-4 · Cited by 278
TGF-β in developmental and fibrogenic EMTs
Lee, J. H., & Massagué, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.004 · Cited by 278
Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects
López-Hernández, F. J., & López-Novoa, J. M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1275-6 · Cited by 276
The Pathophysiology of the Peritoneal Membrane
Devuyst, O., Margetts, P. J., & Topley, N. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070694 · Cited by 271
Saika, S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700375 · Cited by 270
Self-citationChung, A. C. K., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050510 · Cited by 268
TGF-β signaling in the kidney: profibrotic and protective effects
Sureshbabu, A., Muhsin, S. A., & Choi, M. E. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00365.2015 · Cited by 267
Li, Y., Zhang, J., Shi, J., Liu, K., Wang, X., Jia, Y., He, T., Shen, K., Wang, Y., Liu, J., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02290-0 · Cited by 266
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Liu, Y. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00451.2003 · Cited by 265
Fibroblast activation and myofibroblast generation in obstructive nephropathy
Grande, M. T., & López-Novoa, J. M. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.74 · Cited by 265
Ding, Y., Kim, S. L., Lee, S.-Y., Koo, J. K., Wang, Z., & Choi, M. E. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013101068 · Cited by 264
Surendran, K., Schiavi, S., & Hruska, K. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110949 · Cited by 259
Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition
Guarino, M., Tosoni, A., & Nebuloni, M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.02.020 · Cited by 253
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
Autophagy Is a Component of Epithelial Cell Fate in Obstructive Uropathy
Li, L., Zepeda-Orozco, D., Black, R., & Lin, F. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090345 · Cited by 195
Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187
He, Y., Deng, B., Liu, S., Luo, S., Ning, Y., Pan, X., Wan, R., Chen, Y., Zhang, Z., Jiang, J., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18750 · Cited by 114
Ikeda, Y., Ozono, I., Tajima, S., Imao, M., Horinouchi, Y., Izawa-Ishizawa, Y., Kihira, Y., Miyamoto, L., Ishizawa, K., Tsuchiya, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089355 · Cited by 98
“Similar to its role in fibrosis, TGF-b1-Smad3 signaling is a key mediator for triggering EMT in vivo [42].”
BackgroundResident mesenchymal cells and fibrosis
Hutchison, N., Fligny, C., & Duffield, J. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.015 · Cited by 51
“Increased epithelial expression of TGFβ1 is accompanied by activation of intracellular canonical (Smad) and non-canonical (PAK2, c-Abl, Akt, tuberin and mTorC1) signaling pathways in the epithelium itself [75,76].”
BackgroundRyu, J.-K., Piao, S., Shin, H.-Y., Choi, M. J., Zhang, L. W., Jin, H.-R., Kim, W. J., Han, J.-Y., Hong, S. S., Park, S. H., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01216.x · Cited by 48
Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis
Sun, B., Wang, H., Zhang, L., Yang, X., Zhang, M., Zhu, X., Ji, X., & Wang, H. (2018) · Cytokine · doi:10.1016/j.cyto.2017.10.015 · Cited by 47
Ajay, A. K., Zhao, L., Vig, S., Fujiwara, M., Thakurela, S., Jadhav, S., Cho, A., Chiu, I.-J., Ding, Y., Ramachandran, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110473 · Cited by 47
Regulation of Renal Fibrosis by Smad3 Thr388 Phosphorylation
Qu, X., Li, X., Zheng, Y., Ren, Y., Puelles, V. G., Caruana, G., Nikolic-Paterson, D. J., & Li, J. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.12.003 · Cited by 33
Metadata
- Authors
- Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2003-11-14
- Volume
- 112
- Issue
- 10
- Pages
- 1486-1494
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036044995
- Cited by
- 831
- References
- 45
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.